Interview: Bart Roep – Director, Diabetes Expert Center, Leiden…
Winner of the Dutch Prix Corona Gallina in 2011, Prof. Dr. Bart Roep discusses his groundbreaking research into type 1 diabetes; his wishes to deal with the cause rather than…
Address: Albinusdreef 2, 2333 ZA Leiden, the Netherlands
,Netherlands
Tel: +31 71 5269111
Web: https://www.lumc.nl/home/
One of the eight medical centres in the Netherlands, the Leiden University Medical Center (LUMC) has five core tasks:
patient care
scientific research
education
study programmes
continuing education.
The LUMC employs 7000 people.
Patient care is largely focused on highly specialised care, the sort of care that cannot be provided anywhere else. The LUMC also offers a broad package of top-level clinical care, including organ transplants, cardiovascular interventions and all types of bone marrow transplants.
The research conducted in the LUMC is both fundamental and patient- and care-oriented. A considerable portion of the research centres on the translation from fundamental research to its use in patient care (from bench to bedside and vice versa). A good example is the recently opened C.J. Gorter Center, one of the world’s prominent centres in the area of MRI research.
The C.J. Gorter Center has installed the first 7Tesla MRI scanner in the Netherlands for use with humans. The research in the LUMC will be aimed at early diagnosis of Alzheimer’s, a better understanding of migraine, the energy economy in healthy people and patients with diabetes, and the process of ageing. Important research themes in the LUMC are: ageing, neurosciences, vascular medicine, infectious diseases and immunology, cancer immunotherapy, regenerative medicine, oncogenetics, genetic epidemiology and bio-informatics.
The LUMC offers degree courses in Medicine and Biomedical Sciences. The training of medical specialists is also a core task of the LUMC. Medical specialists are trained in 27 specialities in collaborative clusters of general hospitals in the vicinity.
The Boerhaave Committee is another part of the LUMC. Its focus is the provision of high-quality training at post-academic and post-graduate as well post-vocational levels.
patient care
scientific research
education
study programmes
continuing education
Winner of the Dutch Prix Corona Gallina in 2011, Prof. Dr. Bart Roep discusses his groundbreaking research into type 1 diabetes; his wishes to deal with the cause rather than…
Your role as Chair of the Executive Board is a mix between CEO and CMO. On a daily basis, which do you see yourself as more – the Chief Executive…
Kees Smaling, Managing Director of Siemens Healthcare, which recently completed its first Dutch (and European) hospital financing, explains the strategic thinking that sustains Siemens’ shift to become a more comprehensive…
DB Schenker’s Bart Coenen (BC) and Vincent Coolen (VC) explain the company’s Vision 2020 and talk about the benefits for pharma companies of outsourcing their supply chain. In 2013, DB…
Floris Van Haselen, Business Development Director Europe for O&M Movianto, one of the rare logistics companies to be fully specialized and to only operate in the healthcare sector, explains how the company…
Peter Schoevers, CEO and co-founder of Julius Clinical, explains how this innovative and thriving organization allies the academic strength of an ARO with the business-oriented leadership of a CRO. Julius…
Isabelle de Walsche, Managing Director of Gedeon Richter Benelux, provides us with an update on the development of this striving and ambitious player in the women’s healthcare field and shares…
Roeland Van Dam, CEO of Bilthoven Biologicals, a historical Dutch company which remains at the forefront of vaccine production, explains how being integrated into the Serum Institute of India has…
Rob de Roock, Director CL Healthcare for UPS Europe, gives us a brief outline of the current market dynamics impacting the booming European healthcare logistics industry and explains how UPS…
Han Brouwer, General Manager for Actelion in the Netherlands, explains how Opsumit’s successful market launch has strengthened Actelion’s leadership position in the pulmonary arterial hypertension (PAH) field. He calls for…
Bart van de Kerkhof highlights how Covidien’s acquisition will drive Medtronic to new heights thanks to a broader product portfolio. Medtronic is already piloting projects and cooperating with key stakeholders to…
Anita Atema, General Manager of Celgene, reveals Celgene’s inspiring and concrete initiatives that illustrate how a true willingness to cooperate with healthcare stakeholders and a remarkable effort of transparency can help…
Amgen Netherlands is preparing to launch five new products next year, including their leading cardiovascular biotech product Repatha and recently announced the acquisition of the Dutch biotech Dezima. General manager…
Maikel Beerens, CEO and founder of Xilloc, a promising Dutch company that designs patient-specific implants, anatomical models and surgical guides for bone reconstruction or augmentation with the help of 3-D…
See our Cookie Privacy Policy Here
